Drugs / anti-CFA/I bovine IgG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00435526 | Mar → Oct 2006 | diarrheal disease | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anti-CFA/I bovine IgG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00435526 ↗ |
| Modality | Protein / enzyme biologic | “Bovine Milk Immunoglobulin (BIgG)” NCT00435526 ↗ |
| Route | Oral | “Orally Delivered Bovine Milk Immunoglobulin” NCT00435526 ↗ |